Viral Bioinformatics Sequencing and Analysis

The contract requires the performance of high-throughput sequencing on Bundibugyo virus samples, followed by comprehensive genomic analysis and data interpretation to inform and support public health response efforts. The work demands precision in sample processing, accurate sequencing, and robust bioinformatics to extract actionable insights from viral genomic data. All results must be delivered in compliance with standards set by the FDA-ARGOS program, including both finalized analytical reports and raw sequence datasets, ensuring transparency and utility for public health authorities. This subcontract, categorized under NAICS code 541620 for scientific research and development services, is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The opportunity was posted on August 4, 2026, with a firm response deadline of August 10, 2026. While no specific location for performance or point of contact is provided, the deliverables are intended to support a national public health infrastructure, emphasizing rapid data turnaround and rigorous quality control to enable timely responses to viral outbreaks.